TVM Life Science Capital

Discover the Power of AI in Biopharma: TVM to host thought-provoking sessions at BIO-Europe 2024

30 October 2024 – Munich, Germany and Montreal, Quebec, Canada – TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation, today announced that the Company will host a series of sessions focused on the critical role artificial intelligence (AI) plays in the future of the biopharma...
TVM Capital GmbH, TVM Life Science Management GmbH, Ottostraße 4, 80333 Munich, Germany

+49 (89) 998 992-00